Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Spotify Technology (SPOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Spotify Technology — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Spotify Technology trades at $519.03 (market cap $107.72B). The key difference: Spotify Technology is far larger — about 12.1× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Spotify Technology nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Spotify Technology for 111 Days on average.
| KYMR | SPOT | |
|---|---|---|
Market Cap | $8.88B | $107.72B |
Volume | 1,028,790 | 1,447,333 |
Sector | Health | Media |
52-Week High | $127.31 | $689.21 |
52-Week Low | $55.80 | $412.75 |
Typical Hold Time | 0 Days | 111 Days |
Enterprise Value | $8.27B | $97.72B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Spotify (SPOT) trades at $527.45, down 0.26% on the day, with a bullish technical outlook supported by moving averages. The company shows strong fundamental momentum with revenue growing from $11.7B in 2022 to $17.2B in 2025, while achieving profitability with net income reaching $2.2B. Recent earnings show mixed results with Q2 2026 missing expectations, but Q3 2026 results are pending. Analyst consensus remains strongly positive with 62% buy ratings and a $588 price target representing 11% upside.
The outlook remains favorable given Spotify's expanding profit margins and market leadership in audio streaming. Key risks include competitive pressures from tech giants and execution challenges in new markets. With strong institutional support and improving cash flow generation, SPOT offers growth potential but requires monitoring of upcoming earnings and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →
